Muutke küpsiste eelistusi

E-raamat: Hyaluronan Signaling and Turnover

(Department of Biochemistry, University of Nebraska, USA), (Ludwig Institute for Cancer Research Ltd, Sweden)
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 141,96 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics. This volume covers hyaluronan signaling and turnover.
  • Provides information on cancer research
  • Outstanding and original reviews
  • Suitable for researchers and students

Muu info

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics.
Contributors xi
Preface xv
Pt 1 Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy 1(34)
Caitlin O. McAtee
Joseph J. Barycki
Melanie A. Simpson
1 Introduction
2(1)
2 Of Mole Rats and Men: Insights About HA and Cancer
3(3)
3 Hyaluronidase Expression in Cancer
6(5)
4 Hyaluronidase Function and the Metastatic Process
11(7)
5 Hyaluronidase Targeting in Cancer Therapy and Imaging
18(8)
6 Conclusions and Future Perspective
26(1)
Acknowledgments
27(1)
References
27(8)
Pt 2 Targeting Hyaluronic Acid Family for Cancer Chemoprevention and Therapy 35(32)
Vinata B. Lokeshwar
Summan Mirza
Andre Jordan
1 Introduction
36(2)
2 Targeting HA Production
38(5)
3 Targeting HA Signaling
43(2)
4 HA as a Carrier for Drug Delivery
45(3)
5 Targeting HA Receptors
48(5)
6 Targeting HAase
53(1)
7 Conclusion
54(1)
Acknowledgments
55(1)
References
55(12)
Pt 3 Aberrant, Posttranscriptional Processing of Hyaluronan Synthase 1 in Malignant Transformation and Tumor Progression 67(28)
Sophia Adamia
Jitra Kriangkum
Andrew R. Belch
Linda M. Pilarski
1 Splicing and Cancer
68(1)
2 Control of Pre-mRNA Splicing
69(2)
3 Impact on Cancer of Alterations in Splicing Machinery
71(1)
4 Aberrant Splicing of Hyaluronan Synthase 1
72(3)
5 Clinical Impact of Aberrant HAS1 Splicing
75(1)
6 Genetic Variations in HAS1
76(1)
7 Functional Impact of HAS1Vs
76(4)
8 Functional Outcomes of HAS1Vs in Transfectants
80(3)
9 HAS1Vs and Mitotic Catastrophe
83(5)
10 Conclusion
88(1)
Acknowledgments
88(1)
References
88(7)
Pt 4 Hyaluronan Synthases Posttranslational Regulation in Cancer 95(26)
Davide Vigetti
Alberto Passi
1 Introduction
96(2)
2 HA Synthesis
98(3)
3 HA Catabolism
101(2)
4 HAS2 Phosphorylation, AMPK, and Its Dual Effects on Tumors
103(5)
5 O-GIcNAcylation and Cancer
108(5)
6 Conclusions
113(1)
Acknowledgment
113(1)
References
113(8)
Pt 5 Hyaluronan-Coated Extracellular Vesicles-A Novel Link Between Hyaluronan and Cancer 121(28)
Kirsi Rilla
Hanna Siiskonen
Markku Tammi
Raija Tammi
1 Introduction
122(2)
2 Extracellular Vesicles as Novel Communicators Between Cells
124(2)
3 EVs Promote Tumor Progression
126(3)
4 HA Synthesis Enhances Shedding of Extracellular Vesicles
129(8)
5 HA-EVs as Predictors, Targets, and Carriers of Therapy
137(2)
6 Conclusions
139(1)
Acknowledgments
139(1)
References
140(9)
Pt 6 Hyaluronan in the Healthy and Malignant Hematopoietic Microenvironment 149(42)
Sophia K. Khaldoyanidi
Valentina Goncharova
Barbara Mueller
Ingrid U. Schraufstatter
1 Introduction
151(2)
2 BM MSC, Their Derivatives, and HA
153(10)
3 Macrophages and HA in the BM
163(3)
4 Endothelial Cells and HA in BM
166(7)
5 Nerve Cells and HA in BM
173(1)
6 Role of HA in the BM Microenvironment in Hematological Malignancies
174(3)
7 Conclusion
177(1)
References
178(13)
Pt 7 Hyaluronan Regulation of Endothelial Barrier Function in Cancer 191(20)
Patrick A. Singleton
1 Introduction
192(2)
2 HA Regulation of Vascular Integrity
194(3)
3 HA Regulation of Endothelial Barrier Function During Tumor Angiogenesis
197(1)
4 HA Regulation of Endothelial Barrier Function During Cancer Metastasis
198(2)
5 Potential Therapeutic Effects of HMW-HA in Inhibiting Endothelial Barrier Disruption During Cancer Progression
200(1)
6 Conclusions
201(2)
Acknowledgments
203(1)
References
203(8)
Pt 8 HAS2 and CD44 in Breast Tumorigenesis 211(20)
Paraskevi Heldin
Kaustuv Basu
Inna Kozlova
Helena Porsch
1 Introduction
211(2)
2 Molecular Classification of Breast Cancer
213(2)
3 Role of Stromal HA in Tumor Progression
215(3)
4 Expression of HAS Genes and Breast Cancer Malignancy
218(2)
5 HA-CD44 Interactions: A Regulatory Network During TGFp-Mediated EMT
220(3)
6 Conclusions
223(1)
Acknowledgments
223(1)
References
224(7)
Pt 9 CD44 is a Multidomain Signaling Platform that Integrates Extracellular Matrix Cues with Growth Factor and Cytokine Signals 231(24)
Veronique Orian-Rousseau
Jonathan Sleeman
1 Introduction
232(2)
2 Ligation of ECM Components by CD44
234(4)
3 CD44: Coreceptor for Cell-Surface Receptors
238(6)
4 CD44 as a Multidomain Signal Integration Platform
244(4)
5 Concluding Remarks
248(1)
References
249(6)
Pt 10 Hyaluronan-CD44 Interaction Promotes Oncogenic Signaling, microRNA Functions, Chemoresistance, and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression 255(22)
Lilly Y.W. Bourguignon
Marisa Shiina
Jian-Jian Li
1 Introduction
256(2)
2 Regulation of Tumor Progression by HA/CD44
258(3)
3 Activation of CSCs by HA/CD44
261(8)
4 Conclusion
269(1)
Acknowledgments
269(1)
References
270(7)
Pt 11 Advances and Advantages of Nanomedicine in the Pharmacological Targeting of Hyaluronan-CD44 Interactions and Signaling in Cancer 277(42)
Spyros S. Skandalis
Chrisostomi Gialeli
Achilleas D. Theocharis
Nikos K. Karamanos
1 Introduction
278(1)
2 Importance of Targeting Hyaluronan-CD44 in Tumors
279(5)
3 Therapeutic Interventions/Strategies That Target Hyaluronan and/or CD44 to Perturb Hyaluronan-CD44 Interactions in Tumors
284(11)
4 Advances in Nanomedicine Related with Hyaluronan-CD44 Targeting
295(9)
5 Concluding Remarks/Conclusions
304(1)
Acknowledgments
304(1)
References
305(14)
Pt 12 Hyaluronan/RHAMM Interactions in Mesenchymal Tumor Pathogenesis: Role of Growth Factors 319(32)
Katerina Kouvidi
Dragana Nikitovic
Aikaterini Berdiaki
George N. Tzanakakis
1 Introduction
320(3)
2 The Role of Hyaluronan and Its Receptors in Fibrosarcoma
323(9)
3 GF Signaling and ECM Organization in Fibrosarcoma Pathogenesis
332(5)
4 Concluding Remarks
337(1)
References
338(13)
Pt 13 CD147: Regulator of Hyaluronan Signaling in Invasiveness and Chemoresistance 351(24)
G. Daniel Grass
Lu Dai
Zhiqiang Qin
Chris Parsons
Bryan P. Toole
1 Introduction
352(1)
2 Structure and Pleiotropic Functions of CD147
353(3)
3 CD147-Induced HA Synthesis and Signaling
356(1)
4 CD147-HA Axis in Cellular Invasion
356(5)
5 CD147-HA Axis in Chemoresistance
361(2)
6 Induction of the CD147-HA Axis by Kaposi's Sarcoma-Associated Herpesvirus
363(1)
7 Conclusions
364(2)
References
366(9)
Index 375
Paraskevi Heldin, Ph.D., received her B.Sci. exam (Chemistry/Biochemistry Mathematics), Uppsala University in 1979 and her Ph.D., in Medical and Physiological Chemistry for studies on regulatory phosphorylation of proteins, Faculty of Medicine, Uppsala University, in 1987. After dissertation she changed research area and focused on the biology of hyaluronan under the supervision of Professor T.C. Laurent, Uppsala University. She worked at Department of Medical and Physiological Chemistry during 1987- 2000, and was awarded Docent appointment in Medical and Physiological Chemistry and Scientist Position from The Göran Gustafsson Foundation. Since 2001, she is Adjunct Associate Professor at the Department of Medical Biochemistry and Microbiology, and Associate Investigator and Head of the Matrix Biology Group in Ludwig Institute for Cancer Research, Uppsala, Sweden. Year 2013, she has appointed Adjunct Professor at the Department of Medical Biochemistry and Microbiology, Uppsala Unversity, Sweden. Dr Heldins interests are focused on understanding the mechanisms of how hyaluronan-CD44 complexes interact with the receptors for the growth factors PDGF and TGF for modulation of the proliferative and invasive behavior of malignant cells.